Global Cell Surface Markers Identification Industry

LONDON, March 15, 2016 /PRNewswire/ -- This report analyzes the worldwide markets for Cell Surface Markers Identification in US$ Million by the following Product Segments: Flow Cytometers, and Others. The Global market is further analyzed by the following Application Markets: Research, and Diagnosis. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 79 companies including many key and niche players such as -

Abbott Laboratories
BD Biosciences
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
CellaVision AB



Download the full report: https://www.reportbuyer.com/product/3449673/



I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3 Flow Cytometers.............. I-3 Hematology Analyzers..............I-4 Reagents.............. I-4

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW.............. II-1 A Prelude.............. II-1 Increased Emphasis on Lab Automation Builds Opportunities II-2 Market Outlook.............. II-3 Developed Regions: Major Revenue Contributors II-3 Developing Regions: Hotspots for Future Growth II-4 Healthcare Trends Influencing Demand for Healthcare Technologies in Developing Nations: A Review II-4 Growing Healthcare Awareness..............II-4 Increased Access to Healthcare II-5 Proliferation of Medical Tourism II-5 Economic Upheavals in the Recent Past & Impact on Healthcare & Research Equipment Market..............II-5 Stable Spending Outlook Offers Opportunities for Market Growth II-7

2. NOTEWORTHY MARKET TRENDS & GROWTH DRIVERS II-8 Upward Trajectory in Med Tech Sector Gives Impetus to Market Growth.............. II-8 Cell Surface Markers Identification Assumes Critical Importance Amid Growing Prevalence of Chronic Diseases II-8 Cell Surface Markers in Stem Cell Research II-9 Select Cell Surface Marker s Used in Stem Cell Identification and Characterization..............II-10 Increasing Significance in Cancer Research II-11 Increasing Significance in Cancer Research Table 1: Worldwide Incidence of Cancer (2010, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart).............. II-12

Table 2: New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart) II-12

Table 3: Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart) II-13 Clinical Management of Autoimmune Diseases II-13 Flow Cytometry Remains the Gold Standard in HIV Testing and Monitoring.............. II-14 Table 4: Worldwide HIV Prevalence and New Infection Incidence (2014) in Millions (includes corresponding Graph/Chart) II-15

Table 5: HIV Testing Service Penetration, by Region (2010-2014): Percentage Share Breakdown of Adult Population who received HIV Testing Services in Various Global Regions (includes corresponding Graph/Chart) II-15 Increasing Investments on Advanced Equipment in Disease Diagnosis Underpin Volume Growth II-16 High Uptake in Drug Discovery Applications Widens Market Prospects.............. II-16 Growing Focus on Data Management in Research Programs Extends Opportunities.............. II-17 Flow Cytometers: A Standard Research Tool II-17 Technological Advances Boost Cytometric System Sales II-18 Third-party Software - Easing Flow Cytometry Data Analysis and Sharing.............. II-18 Select Leading Software for Flow Cytometry II-19 Hematology Analyzers Gain Traction in Cell Surface Marker Identification.............. II-20 Innovations in Hematology Analyzers Segment II-20 Dry Reagents Find Increased Adoption II-21

3. COMPETITION.............. II-22 Flow Cytometers Market Characterized by High Consolidation II-22 Table 6: Leading Players in the Global Flow Cytometers Market (2014): Percentage Breakdown of Value Sales for Becton Dickinson and Company (BD)/BD Biosciences, Danaher/ Beckman Coulter and Others (includes corresponding Graph/Chart) II-22 Specialist Players Dominate Hematology Analyzers Market II-23 Software and Services: The New Area of Competition in Hematology Analyzers Segment II-23

4. PRODUCT OVERVIEW.............. II-24 Introduction.............. II-24 Types of Cell Surface Markers..............II-24 Applications of Cell Surface Marker Identification II-24 In Assessing Aberrant Cell Populations II-24 In Distinguishing Minimal Residual Disease II-24 To Quantify Cell Populations..............II-24 For Evaluating Cell Proliferation II-25 In Identification of Foreign Cell Populations II-25 In Ascertaining Haematological Condition II-25 Product Segments.............. II-25 Flow Cytometers.............. II-25 Hematology Analyzers..............II-25 Reagents.............. II-26 Kits.............. II-26 End Users.............. II-26 Healthcare Facilities..............II-26 Research Entities..............II-26

5. PRODUCT INTRODUCTIONS/LAUNCHES..............II-27 EIDIA to Introduce HISCL KL-6 Marker Diagnostic Kit II-27 Helomics™ to Unveil Precision Cellular Analytical Platform™ ( PCAP™).............. II-27 Bio-Rad Laboratories Unveils VivaFix™ Cell Viability Assays II-27 EMD Millipore Launches Amnis® NF?B Translocation kit II-27 Sysmex Unveils XN-L Series Automated Hematology Analyzer II-27 Sysmex Launches LC-1000 Exfoliative Cell Analyser II-27 Sysmex Rolls Out HISCL-800 Immunoassay System II-28 HORIBA UK Unveils Pentra XLR Compact 5 Part DIFF Haematology Analyser.............. II-28 Roche Introduces AMH Fertility Marker II-28 Diatron Group Unveils Abacus 3CT Hematology Analyzer II-28 Beckman Coulter Launches UniCel DxH 600 II-28 Sysmex Develops Reagent for Testing Hepatic Fibrosis II-28

6. RECENT INDUSTRY ACTIVITY..............II-29 Beckman Coulter Receives FDA Clearance for AQUIOS CL Flow Cytometer.............. II-29 Bio-Rad Laboratories Extends Agreement with Beckman Coulter II-29 Sysmex to Expand US Reagent Factory II-29 Sysmex to Establish New R&D Lab..............II-29 Siemens Healthcare Joins CANCER-ID Consortium II-29 Sysmex Expands Reagent Factory in Germany II-29 EMD Millipore Collaborates with Sysmex II-30 eBioscience Inks Distribution Agreement with Binding Site Group II-30 The Carlyle Group Acquires Johnson & Johnson's Ortho-Clinical Diagnostics Business..............II-30 Beckman Coulter Bags FDA Clearance for Power Express Sample Processing System..............II-30 Beckman Coulter Signs New Installation Agreement with PCL Alverno II-30 Beckman Coulter Teams Up with hc1.com® II-30 Sysmex Launches i-Square Instrument Factory II-31 Sysmex Renames Partec as Sysmex Partec II-31 Beckman Coulter Life Sciences to Acquire Xitogen Technologies II-31 Sysmex Establishes Sysmex Australia II-31 Beckman Coulter Life Sciences Receives FDA Approval for Navios II-31 Thorlabs Snaps Up CompuCyte..............II-31 Beckman Coulter Inks New Tri Source Agreement with Premier II-31 Beckman Coulter Receives FDA Clearance for its Access AccuTnI +3 Troponin I Assay..............II-32 Sysmex Inks Collaboration Agreement with National Cancer Center II-32 Sysmex Acquires Partec..............II-32 Beckman Coulter Life Sciences Acquires ReaMetrix India's Flow Cytometry Business.............. II-32 Sysmex Takes Over Dong Kang Medipia II-32

7. FOCUS ON SELECT GLOBAL PLAYERS..............II-33 Abbott Laboratories (US)..............II-33 BD Biosciences (US).............. II-33 Beckman Coulter, Inc. (US)..............II-33 Bio-Rad Laboratories, Inc. (US)..............II-34 CellaVision AB (Sweden)..............II-35 Dako Denmark A/S (Denmark)..............II-35 eBioscience, Inc. (US)..............II-35 EMD Millipore (US)..............II-35 F. Hoffmann-La Roche Ltd. (Switzerland) II-36 Grifols, S.A (Spain)..............II-37 Horiba Ltd. (Japan).............. II-37 Mindray Medical International Limited (China) II-37 Ortho-Clinical Diagnostics, Inc. (US) II-38 QIAGEN N.V. (The Netherlands)..............II-38 Siemens Healthcare (Germany)..............II-39 Sysmex Corporation (Japan)..............II-39 Thermo Fisher Scientific, Inc. (US) II-39

8. GLOBAL MARKET PERSPECTIVE..............II-41 Table 7: World Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) II-41

Table 8: World Historic Review for Cell Surface Markers Identification Equipment by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)..............II-42

Table 9: World 14-Year Perspective for Cell Surface Markers Identification Equipment by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart)..............II-43

Table 10: World Recent Past, Current and Future Analysis for Flow Cytometers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............II-44

Table 11: World Historic Review for Flow Cytometers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) II-45

Table 12: World 14-Year Perspective for Flow Cytometers by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart) II-46

Table 13: World Recent Past, Current and Future Analysis for Others by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............II-47

Table 14: World Historic Review for Others by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) II-48

Table 15: World 14-Year Perspective for Others by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart) II-49

Table 16: World Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Application - Research and Diagnosis Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) II-50

Table 17: World Historic Review for Cell Surface Markers Identification Equipment by Application - Research and Diagnosis Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)..............II-51

Table 18: World 14-Year Perspective for Cell Surface Markers Identification Equipment by Application - Percentage Breakdown of Revenues for Research and Diagnosis Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart) II-52

III. MARKET

1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Outlook.............. III-1 Largest Market for Cell Surface Markers Identification Equipment.............. III-1 Increased Focus on Cancer Care to Benefit Market III-1 Cancer Statistics..............III-2 Table 19: New Cancer Cases in the US by Gender and Affected Site: 2014..............III-2

Table 20: Cancer Related Deaths in the US by Gender and Body Site: 2014.............. III-4 Recovery in Lab Investments to Support Growth III-5 Product Innovations Focus on High Volume Applications III-5 Competitive Scenario..............III-6 BD Biosciences & Beckman Coulter Dominate Flow Cytometers Market.............. III-6 Table 21: Leading Players in the US Flow Cytometry Market (2014): Percentage Breakdown of Value Sales for Becton Dickinson and Company (BD)/BD Biosciences, Danaher/ Beckman Coulter and Others (includes corresponding Graph/Chart).............. III-6 Product Launches..............III-7 Strategic Corporate Developments III-7 Select Key Players..............III-9 B.Market Analytics..............III-14 Table 22: US Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-14

Table 23: US Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-15

Table 24: US 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart) III-16

2. CANADA.............. III-17 A.Market Analysis.............. III-17 High Focus on Improving Healthcare Augurs Well for Market Growth.............. III-17 B.Market Analytics..............III-18 Table 25: Canadian Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-18

Table 26: Canadian Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-19

Table 27: Canadian 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).............. III-20

3. JAPAN.............. III-21 A.Market Analysis.............. III-21 Outlook.............. III-21 Product Launches..............III-21 Strategic Corporate Developments III-22 Select Key Players..............III-23 B.Market Analytics..............III-24 Table 28: Japanese Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-24

Table 29: Japanese Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-25

Table 30: Japanese 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).............. III-26

4. EUROPE.............. III-27 A.Market Analysis.............. III-27 Outlook.............. III-27 European Debt Crisis Weakens Market Momentum in 2012 & 2013 III-27 B.Market Analytics..............III-28 Table 31: Europe Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-28

Table 32: Europe Historic Review for Cell Surface Markers Identification Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-29

Table 33: Europe 14-Year Perspective for Cell Surface Markers Identification Equipment by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart) III-30

Table 34: Europe Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-31

Table 35: Europe Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-32

Table 36: Europe 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).............. III-33

4a. FRANCE.............. III-34 A.Market Analysis.............. III-34 Outlook.............. III-34 B.Market Analytics..............III-34 Table 37: French Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-34

Table 38: French Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-35

4b. GERMANY.............. III-36 A.Market Analysis.............. III-36 Outlook.............. III-36 Strategic Corporate Developments III-36 Siemens Healthcare - A Major German Player III-36 B.Market Analytics..............III-37 Table 39: German Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-37

Table 40: German Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-38

4c. ITALY.............. III-39 A.Market Analysis.............. III-39 Outlook.............. III-39 B.Market Analytics..............III-39 Table 41: Italian Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-39

Table 42: Italian Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-40

4d. THE UNITED KINGDOM..............III-41 A.Market Analysis.............. III-41 Outlook.............. III-41 Product Launches..............III-41 B.Market Analytics..............III-42 Table 43: UK Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-42

Table 44: UK Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-43

4e. SPAIN.............. III-44 A.Market Analysis.............. III-44 Outlook.............. III-44 Grifols, S.A - A Major Spanish Player III-44 B.Market Analytics..............III-45 Table 45: Spanish Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-45

Table 46: Spanish Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-46

4f. RUSSIA.............. III-47 A.Market Analysis.............. III-47 Outlook.............. III-47 B.Market Analytics..............III-47 Table 47: Russian Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-47

Table 48: Russian Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-48

4g. REST OF EUROPE.............. III-49 A.Market Analysis.............. III-49 Outlook.............. III-49 Product Launches..............III-49 Select Key Players..............III-49 B.Market Analytics..............III-51 Table 49: Rest of Europe Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-51

Table 50: Rest of Europe Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-52

5. ASIA-PACIFIC.............. III-53 A.Market Analysis.............. III-53 Outlook.............. III-53 Asia-Pacific: The Fastest Growing Regional Market III-53 B.Market Analytics..............III-54 Table 51: Asia-Pacific Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-54

Table 52: Asia-Pacific Historic Review for Cell Surface Markers Identification Equipment by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-55

Table 53: Asia-Pacific 14-Year Perspective for Cell Surface Markers Identification Equipment by Geographic Region - Percentage Breakdown of Revenues for China, India, and Rest of Asia-Pacific Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart) III-56

Table 54: Asia-Pacific Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-57

Table 55: Asia-Pacific Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-58

Table 56: Asia-Pacific 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).............. III-59

5a. CHINA.............. III-60 A.Market Analysis.............. III-60 Outlook.............. III-60 Domestic Companies Compete with MNCs III-60 Corporate Development..............III-60 Mindray Medical International Limited - A Major Chinese Player III-60 B.Market Analytics..............III-61 Table 57: Chinese Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-61

Table 58: Chinese Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-62

5b. INDIA.............. III-63 A.Market Analysis.............. III-63 Outlook.............. III-63 Indian Flow Cytometry Market: An Overview III-63 Table 59: Flow Cytometry Market in India (2014): Percentage Breakdown of Sales by End-Use Industry - Life Sciences, Clinical Research and Pharmaceutical (includes corresponding Graph/Chart)..............III-63

Table 60: Indian Market for Flow Cytometers Reagents (2014): Percentage Share Breakdown of Value Sales by Application (includes corresponding Graph/Chart) III-64 Automated Hematology Analyzers Gaining Traction III-64 Corporate Development..............III-64 B.Market Analytics..............III-65 Table 61: Indian Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-65

Table 62: Indian Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-66

5c. REST OF ASIA-PACIFIC..............III-67 A.Market Analysis.............. III-67 Outlook.............. III-67 Strategic Corporate Developments III-67 B.Market Analytics..............III-68 Table 63: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-68

Table 64: Rest of Asia-Pacific Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-69

6. LATIN AMERICA.............. III-70 A.Market Analysis.............. III-70 Outlook.............. III-70 B.Market Analytics..............III-70 Table 65: Latin America Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-70

Table 66: Latin America Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-71

Table 67: Latin America 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).............. III-72

7. REST OF WORLD.............. III-73 A.Market Analysis.............. III-73 Outlook.............. III-73 B.Market Analytics..............III-73 Table 68: Rest of World Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-73

Table 69: Rest of World Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-74

Table 70: Rest of World 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).............. III-75

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 79 (including Divisions/Subsidiaries - 105)

The United States (47) Canada (1) Japan (8) Europe (30) - France (4) - Germany (8) - The United Kingdom (5) - Italy (1) - Spain (2) - Rest of Europe (10) Asia-Pacific (Excluding Japan) (18) Latin America (1)
Download the full report: https://www.reportbuyer.com/product/3449673/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com